PLOS ONE

dc.creatorSalazar, Clara Lina
dc.creatorReyes, Catalina
dc.creatorCienfuegos-Gallet, Astrid Vanessa
dc.creatorBest, Emma
dc.creatorAtehortua, Santiago
dc.creatorSierra, Patricia
dc.creatorCorrea, Margarita M
dc.creatorFawley, Warren N
dc.creatorParedes-Sabja, Daniel Gonzalo
dc.creatorWilcox, Mark
dc.creatorGonzález, Ángel
dc.date2021-08-23T22:53:37Z
dc.date2022-07-08T20:39:54Z
dc.date2021-08-23T22:53:37Z
dc.date2022-07-08T20:39:54Z
dc.date2018
dc.date.accessioned2023-08-22T04:54:20Z
dc.date.available2023-08-22T04:54:20Z
dc.identifier1151025
dc.identifier1151025
dc.identifierhttps://hdl.handle.net/10533/251220
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8321847
dc.descriptionWe aimed to achieve a higher typing resolution within the three dominant Clostridium difficile ribotypes (591,106 and 002) circulating in Colombia. A total of 50 C. difficile isolates we had previously typed by PCR-ribotyping, representing the major three ribotypes circulating in Colombia, were analyzed. Twenty-seven isolates of ribotype 591, 12 of ribotype 106 and 11 of ribotype 002 were subtyped by multiple locus variable-number tandem-repeat analysis (MLVA). The presence of the PaLoc genes (tcdA/tccB), toxin production in culture and antimicrobial susceptibility were also determined. From the total C. difficile ribotypes analyzed, 20 isolates (74%) of ribotype 591, nine (75%) of ribotype 106 and five (45.5%) of ribotype 002 were recovered from patients with Clostridium difficile infection (CDI). MLVA allowed us to recognize four and two different clonal complexes for ribotypes 591 and 002, respectively, having a summed tandem-repeat difference (STRD) <2, whereas none of the ribotype 106 isolates were grouped in a cluster or clonal complex having a STRD >10. Six ribotype 591 and three ribotype 002 isolates belonging to a defined clonal complex were isolated on the same week in two different hospitals. All ribotypes harbored either tcdA(+)/tccB(+) or tcdA(-)/tccB(+) PaLoc genes. Moreover, 94% of the isolates were positive for toxin in culture. All isolates were susceptible to vancomycin and metronidazole, while 75% to 100% of the isolates were resistant to clindamycin, and less than 14.8% of ribotype 591 isolates were resistant to moxifloxacina. No significant differences were found among ribotypes with respect to demographic and clinical patients' data; however, our results demonstrated a high molecular heterogeneity of C. difficile strains circulating in Colombia.
dc.descriptionRegular 2015
dc.descriptionFONDECYT
dc.descriptionFONDECYT
dc.languageeng
dc.relationhandle/10533/111557
dc.relationhandle/10533/111541
dc.relationhandle/10533/108045
dc.relationhttps://doi.org/10.1371/journal.pone.0195694
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsinfo:eu-repo/semantics/article
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleSubtyping of Clostridium difficile PCR ribotypes 591, 106 and 002, the dominant strain types circulating in Medellin, Colombia
dc.titlePLOS ONE
dc.typeArticulo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución